Communicating about chemotherapy-induced anemia

Brad Davidson, Diane Blum, David Cella, Heidi Hamilton, Lillian Nail, Roger Waltzman

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Many validated instruments exist for determining the impact of chemotherapy-induced anemia and related fatigue on patient quality of life, but few studies analyze how healthcare providers actually discuss these subjects with patients. The authors share their study results on patterns of communication between participating patients and their physicians and allied health professionals. Letters of invitation were mailed to over 1,000 community-based oncologists, 15 of whom met the criteria and agreed to participate in this study on a first-enrolled basis until sufficient participation was ensured. In total, 36 of their patients were audio- and/or video-recorded during their regularly scheduled visits. Post-visit interviews were conducted separately with patients and participating healthcare professionals. Interviews were transcribed and analyzed using sociolinguistic techniques. Although 52% of visit time was spent discussing side effects and symptoms, most discussions of anemia and fatigue lacked specificity necessary to determine their true impact on patients' lives. Physician inquiries regarding fatigue also tended to be too brief to elicit patients' chief concerns. Vocabulary used to discuss anemia and related fatigue was variable and imprecise, and no fatigue assessment instrument was used or referenced in any visit. Community-based oncologists are encouraged to modify their vocabulary and consider incorporating a validated fatigue instrument, either within or before the consultation, to improve the quality of such communication.

    Original languageEnglish (US)
    JournalJournal of Supportive Oncology
    Volume5
    Issue number1
    StatePublished - Jan 2007

    Fingerprint

    Anemia
    Fatigue
    Drug Therapy
    Vocabulary
    Communication
    Interviews
    Physicians
    Allied Health Personnel
    Health Personnel
    Referral and Consultation
    Quality of Life
    Delivery of Health Care

    ASJC Scopus subject areas

    • Cancer Research
    • Oncology

    Cite this

    Davidson, B., Blum, D., Cella, D., Hamilton, H., Nail, L., & Waltzman, R. (2007). Communicating about chemotherapy-induced anemia. Journal of Supportive Oncology, 5(1).

    Communicating about chemotherapy-induced anemia. / Davidson, Brad; Blum, Diane; Cella, David; Hamilton, Heidi; Nail, Lillian; Waltzman, Roger.

    In: Journal of Supportive Oncology, Vol. 5, No. 1, 01.2007.

    Research output: Contribution to journalArticle

    Davidson, B, Blum, D, Cella, D, Hamilton, H, Nail, L & Waltzman, R 2007, 'Communicating about chemotherapy-induced anemia', Journal of Supportive Oncology, vol. 5, no. 1.
    Davidson B, Blum D, Cella D, Hamilton H, Nail L, Waltzman R. Communicating about chemotherapy-induced anemia. Journal of Supportive Oncology. 2007 Jan;5(1).
    Davidson, Brad ; Blum, Diane ; Cella, David ; Hamilton, Heidi ; Nail, Lillian ; Waltzman, Roger. / Communicating about chemotherapy-induced anemia. In: Journal of Supportive Oncology. 2007 ; Vol. 5, No. 1.
    @article{8c884992fd7547ddbf2a2ec01ce8eeb0,
    title = "Communicating about chemotherapy-induced anemia",
    abstract = "Many validated instruments exist for determining the impact of chemotherapy-induced anemia and related fatigue on patient quality of life, but few studies analyze how healthcare providers actually discuss these subjects with patients. The authors share their study results on patterns of communication between participating patients and their physicians and allied health professionals. Letters of invitation were mailed to over 1,000 community-based oncologists, 15 of whom met the criteria and agreed to participate in this study on a first-enrolled basis until sufficient participation was ensured. In total, 36 of their patients were audio- and/or video-recorded during their regularly scheduled visits. Post-visit interviews were conducted separately with patients and participating healthcare professionals. Interviews were transcribed and analyzed using sociolinguistic techniques. Although 52{\%} of visit time was spent discussing side effects and symptoms, most discussions of anemia and fatigue lacked specificity necessary to determine their true impact on patients' lives. Physician inquiries regarding fatigue also tended to be too brief to elicit patients' chief concerns. Vocabulary used to discuss anemia and related fatigue was variable and imprecise, and no fatigue assessment instrument was used or referenced in any visit. Community-based oncologists are encouraged to modify their vocabulary and consider incorporating a validated fatigue instrument, either within or before the consultation, to improve the quality of such communication.",
    author = "Brad Davidson and Diane Blum and David Cella and Heidi Hamilton and Lillian Nail and Roger Waltzman",
    year = "2007",
    month = "1",
    language = "English (US)",
    volume = "5",
    journal = "Journal of Supportive Oncology",
    issn = "1544-6794",
    publisher = "Biolink Communications, Inc.",
    number = "1",

    }

    TY - JOUR

    T1 - Communicating about chemotherapy-induced anemia

    AU - Davidson, Brad

    AU - Blum, Diane

    AU - Cella, David

    AU - Hamilton, Heidi

    AU - Nail, Lillian

    AU - Waltzman, Roger

    PY - 2007/1

    Y1 - 2007/1

    N2 - Many validated instruments exist for determining the impact of chemotherapy-induced anemia and related fatigue on patient quality of life, but few studies analyze how healthcare providers actually discuss these subjects with patients. The authors share their study results on patterns of communication between participating patients and their physicians and allied health professionals. Letters of invitation were mailed to over 1,000 community-based oncologists, 15 of whom met the criteria and agreed to participate in this study on a first-enrolled basis until sufficient participation was ensured. In total, 36 of their patients were audio- and/or video-recorded during their regularly scheduled visits. Post-visit interviews were conducted separately with patients and participating healthcare professionals. Interviews were transcribed and analyzed using sociolinguistic techniques. Although 52% of visit time was spent discussing side effects and symptoms, most discussions of anemia and fatigue lacked specificity necessary to determine their true impact on patients' lives. Physician inquiries regarding fatigue also tended to be too brief to elicit patients' chief concerns. Vocabulary used to discuss anemia and related fatigue was variable and imprecise, and no fatigue assessment instrument was used or referenced in any visit. Community-based oncologists are encouraged to modify their vocabulary and consider incorporating a validated fatigue instrument, either within or before the consultation, to improve the quality of such communication.

    AB - Many validated instruments exist for determining the impact of chemotherapy-induced anemia and related fatigue on patient quality of life, but few studies analyze how healthcare providers actually discuss these subjects with patients. The authors share their study results on patterns of communication between participating patients and their physicians and allied health professionals. Letters of invitation were mailed to over 1,000 community-based oncologists, 15 of whom met the criteria and agreed to participate in this study on a first-enrolled basis until sufficient participation was ensured. In total, 36 of their patients were audio- and/or video-recorded during their regularly scheduled visits. Post-visit interviews were conducted separately with patients and participating healthcare professionals. Interviews were transcribed and analyzed using sociolinguistic techniques. Although 52% of visit time was spent discussing side effects and symptoms, most discussions of anemia and fatigue lacked specificity necessary to determine their true impact on patients' lives. Physician inquiries regarding fatigue also tended to be too brief to elicit patients' chief concerns. Vocabulary used to discuss anemia and related fatigue was variable and imprecise, and no fatigue assessment instrument was used or referenced in any visit. Community-based oncologists are encouraged to modify their vocabulary and consider incorporating a validated fatigue instrument, either within or before the consultation, to improve the quality of such communication.

    UR - http://www.scopus.com/inward/record.url?scp=33847657031&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33847657031&partnerID=8YFLogxK

    M3 - Article

    VL - 5

    JO - Journal of Supportive Oncology

    JF - Journal of Supportive Oncology

    SN - 1544-6794

    IS - 1

    ER -